Altium Capital Management LLC In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 15, 2024), Altium Capital Management LLC reported 45 stock positions worth $241.2 million . Its top holding was Vera Therapeutics (VERA) at 10.7% of the portfolio, followed by Adma Biologics (ADMA, 7.0% ) and Xenon Pharmaceuticals (XENE, 5.8% ). Compared with Q1 2024, it opened 16 new positions, sold out of 17, added to 13 and reduced 12. The biggest buy was a new position in Sarepta Therapeutics (SRPT) and the biggest sale an exit from Biohaven (BHVN).
Location NEW YORK, NY
CIK 0001746382
Portfolio Value $241.2M (Q2 2024) Holdings 45 stocks · $241.2M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q1 2024 VERA Vera Therapeutics Inc. 714,000 $25.8M Add +0.6% ADMA Adma Biologics Inc. 1,510,000 $16.9M Reduce -1.9% XENE Xenon Pharmaceuticals Inc. 360,600 $14.1M Add +3.6% ITCI Intra-Cellular Therapies Inc. 193,000 $13.2M Add +70.8% SRPT Sarepta Therapeutics Inc. 81,900 $12.9M New INSM Insmed Inc. 190,000 $12.7M Add +58.3% ALIM Alimera Sciences Inc. 2,150,000 $12.0M Reduce -15.7% SKYE Skye Bioscience Inc. 1,350,093 $10.8M New ARGX Argenx SE - ADR 23,000 $9.9M New SLNO Soleno Therapeutics Inc. 212,909 $8.7M Add +39.2% AVDL Avadel Pharmaceuticals Ltd. 610,000 $8.6M Add +10.3% CPRX Catalyst Pharmaceuticals Inc. 500,000 $7.7M No change CTNM Contineum Therapeutics Inc. Class A 429,340 $7.6M New RZLT Rezolute Inc. 1,700,000 $7.3M New ASND Ascendis Pharma A/S 50,000 $6.8M Add +100.0% VKTX Viking Therapeutics Inc. 122,000 $6.5M Add +43.5% SVRA Savara Inc. 1,575,000 $6.3M Add +18.0% ZVRA Zevra Therapeutics Inc. 1,162,416 $5.7M Add +240.4% MLTX Moonlake Immunotherapeutics 115,000 $5.1M New LRMR Larimar Therapeutics Inc. 693,000 $5.0M Reduce -0.3% XTNT Xtant Medical Holdings Inc. 7,415,413 $4.7M Reduce -3.0% AXSM Axsome Therapeutics Inc. 50,000 $4.0M Reduce -63.8% REAL The Realreal Inc. filed as THE REALREAL INC 1,250,238 $4.0M Add +56.3% CYBIN INC 13,953,488 $3.8M No change OTLK Outlook Therapeutics Inc. 501,785 $3.7M New RARE Ultragenyx Pharmaceutical Inc. 70,000 $2.9M New ORIC Oric Pharmaceuticals Inc. 405,000 $2.9M No change VERU Veru Inc. 2,276,692 $1.9M Add +7.8% CATX Perspective Therapeutics Inc. 191,450 $1.9M New MIST Milestone Pharmaceuticals Inc. 1,012,368 $1.3M Reduce -16.5% ACHV Achieve Life Sciences Inc. 216,310 $1.0M Reduce -74.1% ALLURION TECHNOLOGIES INC 969,840 $968K New BIOVIE INC 1,982,341 $794K Reduce -34.2% CNTX Context Therapeutics Inc. 360,001 $722K New KPTI Karyopharm Therapeutics Inc. 740,000 $642K No change APRE Aprea Therapeutics Inc. 137,197 $558K New SPRB Spruce Biosciences Inc. 811,167 $420K Reduce -29.5% EVOK Evoke Pharma Inc. 692,440 $366K Reduce -4.5% BOLD Boundless Bio Inc. 83,149 $322K Reduce -58.4% LXRX Lexicon Pharmaceuticals Inc. 121,986 $205K New INTELLIGENT BIO SOLUTIONS IN 83,906 $161K New PMNT Perfect Moment Ltd. 62,835 $135K Reduce -31.9% CETX Cemtrex Inc. 339,961 $75K New QUOIN PHARMACEUTICALS LTD 103,127 $60K Add +55.7% APPLIED DNA SCIENCES INC 86,152 $35K New
Options reported separately and not counted above: LRMR calls ($1.4M), ANVS puts ($895K), RAPT THERAPEUTICS INC calls ($610K), SVRA calls ($81K).
Other holdings (19): bonds, preferreds, convertibles and warrants · $954K (not counted above) Security Class Shares / Principal Value Change FATBW Fat Brands Inc. -CW25 *W EXP 07/16/202 200,000 $569K No change NXGLW Nexgel Inc. -CW26 *W EXP 12/27/202 225,000 $98K No change WLDSW Wearable Devices Ltd. - 27 *W EXP 09/14/202 1,411,600 $70K No change ONFOW Onfolio Holdings Inc. -27 *W EXP 01/02/202 200,000 $50K No change RCKTW Rocket Pharmaceuticals in-27 *W EXP 09/02/202 731,561 $44K No change NXLIW Nexalin Technology Inc.- 27 *W EXP 99/99/999 105,000 $36K No change VSEEW Digital Health Acquist-CW23 *W EXP 99/99/999 150,000 $32K New MOBXW Chavrant Capital Acq -CW23 *W EXP 12/21/202 150,000 $27K No change NLSPW NLS Pharmaceutics Ltd. -CW25 *W EXP 02/02/202 200,000 $7K No change BNCWW Cea Industries Inc. -CW27 *W EXP 02/11/202 250,000 $4K No change CYCUW Cycurion Inc.-CW27 *W EXP 02/13/203 100,000 $4K No change CINGW Cingulate -CW23 *W EXP 12/10/202 270,000 $3K No change BTMWQ Bitcoin Depot Inc.-CW23 *W EXP 06/30/202 50,000 $2K No change NEXRW Jeffs Brands Ltd. -27 *W EXP 08/26/202 68,681 $2K No change CDTTW Murphy Canyon Acq-CW27 *W EXP 09/22/202 100,000 $2K No change MITAW Coliseum Acquisition A -CW28 *W EXP 08/22/202 28,333 $1K No change SRZNW Surrozen Inc.-CW25 *W EXP 08/01/203 82,233 $1K No change SLNWF Selina Hospitality PLC-27 *W EXP 10/27/202 101,439 $1K No change TCBWF TC Biopharm Holdings Ltd. *W EXP 02/10/202 18,823 $235 No change
Total filed on the 13F, all lines: $242.1M.
Portfolio Sells Q1 2024 → Q2 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2024 % Of Portfolio Change To Portfolio ▲ BHVN Biohaven Ltd. Sold out 0.00% −3.44 AXSM Axsome Therapeutics Inc. Reduce -63.8% 1.67% −3.29 OLMA Olema Pharmaceuticals Inc. Sold out 0.00% −3.08 MIRM Mirum Pharmaceuticals Inc. Sold out 0.00% −2.35 NGNE Neurogene Inc. Sold out 0.00% −2.29 PRAX Praxis Precision Medicines I Sold out 0.00% −2.14 XTNT Xtant Medical Holdings Inc. Reduce -3.0% 1.94% −2.09 LBPH Longboard Pharmaceuticals Inc. Sold out 0.00% −1.65 ALPN Alpine Immune Sciences Inc. Sold out 0.00% −1.39 ACHV Achieve Life Sciences Inc. Reduce -74.1% 0.42% −1.29 AQST Aquestive Therapeutics Inc. Sold out 0.00% −1.27 BOLD Boundless Bio Inc. Reduce -58.4% 0.13% −1.15 RYTM Rhythm Pharmaceuticals Inc. Sold out 0.00% −1.12 ATXS Astria Therapeutics Inc. Sold out 0.00% −0.90 MRNS Marinus Pharmaceuticals Inc. Sold out 0.00% −0.72 TRML Tourmaline Bio Inc. Sold out 0.00% −0.67 MIST Milestone Pharmaceuticals Inc. Reduce -16.5% 0.55% −0.42 BIOVIE INC Reduce -34.2% 0.33% −0.39 LRMR Larimar Therapeutics Inc. Reduce -0.3% 2.08% −0.29 CATX Perspective Therapeutics Inc. Sold out 0.00% −0.29 SPRB Spruce Biosciences Inc. Reduce -29.5% 0.17% −0.23 PMNT Perfect Moment Ltd. Reduce -31.9% 0.06% −0.09 MOBILICOM LTD Sold out 0.00% −0.07 GRI BIO INC Sold out 0.00% −0.06 EVOK Evoke Pharma Inc. Reduce -4.5% 0.15% −0.05 AZITRA INC Sold out 0.00% −0.05 VSEEW Digital Health Acquisition C Sold out 0.00% −0.01 ALIM Alimera Sciences Inc. Reduce -15.7% 4.96% +0.48 ADMA Adma Biologics Inc. Reduce -1.9% 7.00% +2.43
Portfolio Buys Q1 2024 → Q2 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q1 2024 % Of Portfolio Change To Portfolio ▼ SRPT Sarepta Therapeutics Inc. New 5.37% +5.37 SKYE Skye Bioscience Inc. New 4.48% +4.48 ARGX Argenx SE - ADR New 4.10% +4.10 INSM Insmed Inc. Add +58.3% 5.28% +3.81 CTNM Contineum Therapeutics Inc. Class A New 3.14% +3.14 RZLT Rezolute Inc. New 3.03% +3.03 MLTX Moonlake Immunotherapeutics New 2.10% +2.10 ITCI Intra-Cellular Therapies Inc. Add +70.8% 5.48% +1.96 OTLK Outlook Therapeutics Inc. New 1.54% +1.54 ZVRA Zevra Therapeutics Inc. Add +240.4% 2.36% +1.47 RARE Ultragenyx Pharmaceutical Inc. New 1.19% +1.19 ASND Ascendis Pharma A/S Add +100.0% 2.83% +1.13 CATX Perspective Therapeutics Inc. New 0.79% +0.79 SLNO Soleno Therapeutics Inc. Add +39.2% 3.60% +0.66 ALLURION TECHNOLOGIES INC New 0.40% +0.40 CNTX Context Therapeutics Inc. New 0.30% +0.30 REAL The Realreal Inc. Add +56.3% 1.65% +0.25 APRE Aprea Therapeutics Inc. New 0.23% +0.23 VERU Veru Inc. Add +7.8% 0.79% +0.13 LXRX Lexicon Pharmaceuticals Inc. New 0.09% +0.09 INTELLIGENT BIO SOLUTIONS IN New 0.07% +0.07 CETX Cemtrex Inc. New 0.03% +0.03 APPLIED DNA SCIENCES INC New 0.01% +0.01 QUOIN PHARMACEUTICALS LTD Add +55.7% 0.02% −0.00 SVRA Savara Inc. Add +18.0% 2.63% −0.36 VKTX Viking Therapeutics Inc. Add +43.5% 2.68% −0.45 AVDL Avadel Pharmaceuticals Ltd. Add +10.3% 3.56% −0.65 XENE Xenon Pharmaceuticals Inc. Add +3.6% 5.83% −0.91 VERA Vera Therapeutics Inc. Add +0.6% 10.71% −3.06
Options Activity Q1 2024 → Q2 2024 Security Type Change vs Q1 2024 Underlying Shares Value ▼ VIKING THERAPEUTICS INC put Sold out 175,300 $14.4Mbefore exit ADVISORSHARES TR call Sold out 1,125,000 $11.3Mbefore exit RAPT THERAPEUTICS INC call Sold out 200,000 $1.8Mbefore exit LRMR Larimar Therapeutics Inc. call New 196,000 $1.4M GERON CORP call Sold out 400,000 $1.3Mbefore exit ANVS Annovis Bio put New 155,300 $895K RAPT THERAPEUTICS INC call New 200,000 $610K SVRA Savara Inc. call New 20,000 $81K
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
Notes & Other Activity Q1 2024 → Q2 2024 Security Class Change vs Q1 2024 Shares / Principal Value ▼ MBTCR Nocturne Acquisition-Rights RIGHT 12/26/2025 Sold out 500,000 $82Kbefore exit VSEEW Digital Health Acquist-CW23 *W EXP 99/99/999 New 150,000 $32K OSPWQ Prosomnus Inc.-CW27 *W EXP 04/20/202 Sold out 150,000 $3Kbefore exit BRSWF Bruush Oral Care Inc. -27 *W EXP 08/03/202 Sold out 14,423 $110before exit RACYW Relativity Acquisition-CW27 *W EXP 12/15/202 Sold out 100,000 $0before exit
Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 19 $47.5M RMT, ASA, RVT, NBXG, PDX Q1 2026 19 $42.0M PDX, ASA, RVT, XPCQX, GAM Q4 2025 18 $25.3M ASA, RVT, PDX, NBXG, XPCQX Q3 2025 1 $628K CNSY Q2 2025 0 $0 Q1 2025 Amended 22 $34.4M ZVRA, EOLS, XTNT, AVDL, CTNM Q4 2024 61 $321.1M ADMA, VERA, SRPT, ZVRA, ESTA Q3 2024 57 $334.9M VERA, ADMA, SRPT, EW, XENE Q2 2024 45 $241.2M VERA, ADMA, XENE, ITCI, SRPT Q1 2024 46 $222.3M VERA, XENE, AXSM, ADMA, ALIM